Your browser doesn't support javascript.
loading
Duodenal adenocarcinoma at stage IV: A critical look at diagnostic pathways and treatment modalities.
Grabill, Nathaniel; Louis, Mena; Cawthon, Mariah; Gherasim, Claudia; Walker, Travelyan.
Afiliación
  • Grabill N; Northeast Georgia Medical Center, General Surgery Department, Gainesville, GA 30501, USA.
  • Louis M; Northeast Georgia Medical Center, General Surgery Department, Gainesville, GA 30501, USA.
  • Cawthon M; Northeast Georgia Medical Center, General Surgery Department, Gainesville, GA 30501, USA.
  • Gherasim C; Northeast Georgia Medical Center, Pathology Department, Gainesville, GA 30501, USA.
  • Walker T; Northeast Georgia Medical Center, General Surgery Department, Braselton, GA, 30517, USA.
Radiol Case Rep ; 19(10): 4662-4669, 2024 Oct.
Article en En | MEDLINE | ID: mdl-39220783
ABSTRACT
Duodenal adenocarcinoma is a rare and aggressive gastrointestinal malignancy that frequently presents with symptoms like gastric outlet obstruction and biliary obstruction, leading to delayed diagnosis and challenging prognosis. This case report explores the clinical presentation, diagnostic hurdles, and therapeutic management of late-stage duodenal adenocarcinoma in a 53-year-old woman with no significant prior medical history. The patient presented with severe epigastric pain radiating to the right upper quadrant, nausea, and decreased appetite. Elevated liver enzymes and imaging revealed multiple liver masses and a primary duodenal mass. Biopsies confirmed moderately differentiated adenocarcinoma. Tumor markers were evaluated during the staging phase, showing markedly elevated levels. The patient underwent systemic chemotherapy with FOLFOX but faced complications, including pulmonary emboli and neurological symptoms. Management required a multidisciplinary approach, integrating palliative and supportive care to address symptoms and improve quality of life. The case highlights the necessity of considering duodenal adenocarcinoma when diagnosing persistent gastrointestinal symptoms. It highlights the need for a holistic treatment approach, including tailored chemotherapy regimens and vigilant monitoring of complications. Molecular profiling was crucial in guiding treatment decisions, although MSI, HER2, and PD-1 were negative, and the tumor showed no mismatch repair protein deficiency. This article emphasizes the importance of early integration of palliative care and the value of comprehensive pathological analysis in managing advanced duodenal adenocarcinoma, providing insights into diagnostic and therapeutic strategies for this complex case.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Radiol Case Rep Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Radiol Case Rep Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos